UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer

Scientific reports, 2021-10, Vol.11 (1), p.20059-20059, Article 20059

2021

Volltextzugriff (PDF)

Immune hemolytic anemia--selected topics

Hematology, 2009, Vol.2009 (1), p.80-86

Hoffman, Philip C

2009

Volltextzugriff (PDF)

Phase I Study of G3139, a bcl-2 Antisense Oligonucleotide, Combined With Carboplatin and Etoposide in Patients With Small-Cell Lung Cancer

Journal of clinical oncology, 2004-03, Vol.22 (6), p.1110-1117

2004

Volltextzugriff (PDF)

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

Journal of clinical oncology, 2015-12, Vol.33 (34), p.4007-4014

2015

Volltextzugriff (PDF)

A Phase I Study of Pemetrexed, Carboplatin, and Concurrent Radiotherapy in Patients with Locally Advanced or Metastatic Non–Small Cell Lung or Esophageal Cancer

Clinical cancer research, 2007-01, Vol.13 (2), p.515-522

2007

Volltextzugriff (PDF)

Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease

Cancer, 2012-06, Vol.118 (11), p.2962-2970

2012

Volltextzugriff (PDF)

Immune hemolytic anemia--selected topics

Hematology, 2006, Vol.2006 (1), p.13-18

Hoffman, Philip C

2006

Volltextzugriff (PDF)

A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study

Journal of thoracic oncology, 2022-01, Vol.17 (1), p.130-140

2022

Volltextzugriff (PDF)

Supporting family conversations and children's STEM learning in a children's museum

Early childhood research quarterly, 2014, Vol.29 (3), p.333-344

2014

Volltextzugriff (PDF)

Development and Scale-Up of a Continuous Aerobic Oxidative Chan–Lam Coupling

Organic process research & development, 2019-08, Vol.23 (8), p.1484-1498

2019

Volltextzugriff (PDF)

Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression

Clinical lung cancer, 2023-05, Vol.24 (3), p.e117-e121

2023

Volltextzugriff (PDF)

Stereotactic body radiotherapy for multisite extracranial oligometastases

Cancer, 2012-06, Vol.118 (11), p.2962-2970

2012

Volltextzugriff (PDF)

Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer

Journal of thoracic oncology, 2012-02, Vol.7 (2), p.376-381

2012

Volltextzugriff (PDF)

Development and Manufacturing GMP Scale-Up of a Continuous Ir-Catalyzed Homogeneous Reductive Amination Reaction

Organic process research & development, 2016-11, Vol.20 (11), p.1870-1898

2016

Volltextzugriff (PDF)

Sex-associated differences in survival of patients undergoing resection for lung cancer

The Annals of thoracic surgery, 2000-01, Vol.69 (1), p.245-249

2000

Volltextzugriff (PDF)

Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015

Breast cancer research and treatment, 2020-06, Vol.181 (3), p.623-633

2020

Volltextzugriff (PDF)

Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction

Medical oncology (Northwood, London, England), 2011-12, Vol.28 (Suppl 1), p.152-161

2011

Volltextzugriff (PDF)

Phase II trial of temsirolimus in patients with metastatic breast cancer

Breast cancer research and treatment, 2012-11, Vol.136 (2), p.355-363

2012

Volltextzugriff (PDF)

A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer

SpringerPlus, 2016-06, Vol.5 (1), p.947-947, Article 947

2016

Volltextzugriff (PDF)

Cracking the Code: Using Personal Narratives in Research

Journal of cognition and development, 2013-07, Vol.14 (3), p.361-375

2013

Volltextzugriff (PDF)

Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer

Journal of thoracic oncology, 2008-09, Vol.3 (9), p.1003-1011

2008

Volltextzugriff (PDF)

Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer

BMC cancer, 2014-01, Vol.14 (1), p.5-5, Article 5

2014

Volltextzugriff (PDF)

Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases

Journal of neurology research, 2012-02, Vol.2 (1), p.1-9

2012

Volltextzugriff (PDF)

Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers

American journal of clinical oncology, 2007-06, Vol.30 (3), p.258-263

2007

Volltextzugriff (PDF)

1 – 25 von 405

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(366)
Mit Volltextzugriff
(345)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(267)
Life Sciences & Biomedicine
(244)
Humans
(222)
Female
(154)
Male
(146)
Middle Aged
(115)
Adult
(96)
Aged
(92)
Biological And Medical Sciences
(90)
Medical Sciences
(80)
Oncology
(50)
Respiratory System
(48)
Animals
(34)
General & Internal Medicine
(32)
Lung Neoplasms - Drug Therapy
(30)
Treatment Outcome
(29)
Chronic Obstructive Pulmonary Disease
(28)
Aged, 80 And Over
(27)
Surgery
(27)
Risk Factors
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer

Immune hemolytic anemia--selected topics

Phase I Study of G3139, a bcl-2 Antisense Oligonucleotide, Combined With Carboplatin and Etoposide in Patients With Small-Cell Lung Cancer

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

A Phase I Study of Pemetrexed, Carboplatin, and Concurrent Radiotherapy in Patients with Locally Advanced or Metastatic Non–Small Cell Lung or Esophageal Cancer

Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease

Immune hemolytic anemia--selected topics

A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study

Supporting family conversations and children's STEM learning in a children's museum

Development and Scale-Up of a Continuous Aerobic Oxidative Chan–Lam Coupling

Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression

Stereotactic body radiotherapy for multisite extracranial oligometastases

Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer

Development and Manufacturing GMP Scale-Up of a Continuous Ir-Catalyzed Homogeneous Reductive Amination Reaction

Sex-associated differences in survival of patients undergoing resection for lung cancer

Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015

Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction

Phase II trial of temsirolimus in patients with metastatic breast cancer

Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation

A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer

Cracking the Code: Using Personal Narratives in Research

Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer

Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer

Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases

Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers

Suchergebnisse filtern